Global Beta-Nicotinamide Mononucleotide (NMN) Competitive Landscape Professional Research Report 2024

Global Beta-Nicotinamide Mononucleotide (NMN) Competitive Landscape Professional Research Report 2024

Research Summary

Beta-Nicotinamide Mononucleotide (NMN) is a compound involved in the production of a molecule called nicotinamide adenine dinucleotide (NAD+), which plays a crucial role in cellular energy metabolism and various biological processes. NMN is a precursor to NAD+ and is converted into NAD+ through enzymatic reactions in the body. NAD+ is essential for proper functioning of enzymes called sirtuins, which are involved in regulating cellular processes such as DNA repair, gene expression, and energy metabolism. NMN has garnered attention due to its potential anti-aging properties and its ability to support cellular health. It is believed that NMN supplementation may help increase NAD+ levels, thereby promoting cellular energy production and potentially counteracting some age-related decline in various tissues. NMN is being studied for its potential benefits in improving metabolic health, enhancing exercise performance, and mitigating age-related diseases. However, further research is needed to fully understand its effects and optimal usage.

According to DIResearch's in-depth investigation and research, the global Beta-Nicotinamide Mononucleotide (NMN) market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.

The major global manufacturers of Beta-Nicotinamide Mononucleotide (NMN) include GeneHarbor, Herbalmax, Genex Formulas, Shinkowa Pharmaceutical, Maac10 Formulas, EffePharm, Bontac, Kingdomway, CELFULL etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Beta-Nicotinamide Mononucleotide (NMN). Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Beta-Nicotinamide Mononucleotide (NMN) market. The report data covers historical data from 2018 to 2023, based year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Beta-Nicotinamide Mononucleotide (NMN) market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Beta-Nicotinamide Mononucleotide (NMN) industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.    

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Beta-Nicotinamide Mononucleotide (NMN) Include:

GeneHarbor

Herbalmax

Genex Formulas

Shinkowa Pharmaceutical

Maac10 Formulas

EffePharm

Bontac

Kingdomway

CELFULL

Beta-Nicotinamide Mononucleotide (NMN) Product Segment Include:

Content Greater than or Equal to 98%

Content Less than 98%

Beta-Nicotinamide Mononucleotide (NMN) Product Application Include:

Health Care Products

Cosmetics

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Beta-Nicotinamide Mononucleotide (NMN) Capacity and Production Analysis

Chapter 3: Global Beta-Nicotinamide Mononucleotide (NMN) Industry PESTEL Analysis

Chapter 4: Global Beta-Nicotinamide Mononucleotide (NMN) Industry Porter’s Five Forces Analysis

Chapter 5: Global Beta-Nicotinamide Mononucleotide (NMN) Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 6: Global Beta-Nicotinamide Mononucleotide (NMN) Market Size and Forecast by Type and Application Analysis

Chapter 7: North America Beta-Nicotinamide Mononucleotide (NMN) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: Europe Beta-Nicotinamide Mononucleotide (NMN) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: China Beta-Nicotinamide Mononucleotide (NMN) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: APAC (Excl. China) Beta-Nicotinamide Mononucleotide (NMN) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Latin America Beta-Nicotinamide Mononucleotide (NMN) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 13: Global Beta-Nicotinamide Mononucleotide (NMN) Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 14: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 15: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 16: Research Findings and Conclusion

Chapter 17: Methodology and Data Sources